Health Tuesday is a series of networking events addressing health and wellbeing themes. The event is organized by Business Finland on the first Tuesday of each month and it offers participants an excellent opportunity to discuss with health professionals, health tech companies, decision-makers, investors, and representatives of the public sector.
The next health Tuesday will cover the topic of vaccine research in Finland.
Time: 1 March 2022, 8:00 – 9:00
Place: Online
Registrations: https://businessfinlandmarketing.microsoftcrmportals.com/event/registration?id=Health_Tuesday_March2035835247
The history of vaccine development has seen many great achievements and also Finland has a long history of successful vaccine research and development. Today vaccines are a “hot topic” due to the COVID-19 pandemic. There has been a lot of activities in Finland recently related to vaccines, e.g. a new company Rokote Laboratories Finland Oy was established based on academic research and also another new company Rokotetutkimuskeskus Finvac Oy was established, owned by the University of Tampere and Finnish Institute for Health and Welfare THL.
AGENDA
8.00 Opening Words
Sampo Sammalisto, Head of Personalized Health Finland, Business Finland
8.05 Different phases of vaccine development (at the Tampere University Vaccine Research Center)
Mika Rämet, Director of Vaccine Research Center, Professor, University of Tampere
8.20 THL strategy for vaccine trials and the new company with Tampere University
Arto Palmu, Research manager, Clinical Vaccine Research, Finnish Institute for Health and Welfare, THL
8.35 Rokote Laboratories Finland Oy – Finnish vaccine development company
Tuija Keinonen, CEO and Erkko Ylösmäki, Director, R&D, Rokote Laboratories Finland Oy
8.50 Closing words
Sampo Sammalisto, Head of Personalized Health Finland, Business Finland
9.00 Health Tuesday event ends
Contact person
Sampo Sammalisto
Head of Personalized Health Finland Program
sampo.sammalisto@businessfinland.fi
Source: Business Finland